Sang-A Kim Byoung Soo Kwon Jin-Haeng Chung Ji Yun Lee Soo-Mee Bang Jeong-Ok Lee
10.1177/17534666221135322
Ther Adv Respir Dis
2022 Jan-Dec;16:17534666221135322.
case report chronic myeloid leukemia dasatinib drug-induced interstitial lung disease tyrosine kinase inhibitor
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36346055/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / chemically induced Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Lung Diseases, Interstitial / chemically induced Lung Diseases, Interstitial / diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / chemically induced Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Lung Diseases, Interstitial / chemically induced Lung Diseases, Interstitial / diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Review Case Reports Adult Dasatinib / adverse effects Female Humans Male Middle Aged Philadelphia Chromosome Protein Kinase Inhibitors / therapeutic use Pyrimidines / adverse effects Thiazoles / adverse effects Dasatinib Pyrimidines Thiazoles Protein Kinase Inhibitors
PMC9647296
36346055
Interstitial pneumonitis associated with dasatinib treatment for chronic myeloid leukemia or acute lymphoblastic leukemia: case series and a literature review
2022